Finanse publiczne · 26/09/2014
Branded Prescription Drug Fee; Correction
The Internal Revenue Service (IRS) has released a correction to a notice of proposed rulemaking regarding the branded prescription drug fee, which was initially published on July 28, 2014. The correction addresses temporary regulations related to the fee, specifically modifying the definition of controlled group.